Target cell limited and immune control models of HIV infection: A comparison

被引:261
作者
De Boer, RJ
Perelson, AS
机构
[1] Univ Utrecht, NL-3584 CH Utrecht, Netherlands
[2] Univ Calif Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA
关键词
D O I
10.1006/jtbi.1997.0548
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We develop various mathematical models of the clinical latency stage of HIV-I infection assuming that HIV-1 infection is limited either by the availability of cells that HIV can infect or by a specific anti-HIV cellular immune response. The former models we call "target-cell-limited". Comparing the models by phase plane analysis we find that they all belong to the class of predator-prey models. In the target-cell-limited models the virus is a predator feeding upon target cell prey, while in the immune-control models the virus is a prey that is controlled by an immune response predator. Because both classes of models are of predator-prey type they behave similarly in most circumstances. We find that both types of model can account for the generic picture of disease progression in which the CD4 T cell count slowly decreases and the viral load slowly increases. Additionally, we find that both types of models can adequately describe the clinically observed changes in the plasma HIV-I RNA loads in response to retroviral therapies. (C) 1998 Academic Press Limited.
引用
收藏
页码:201 / 214
页数:14
相关论文
共 74 条
  • [1] THE FALLACIES OF RATIO-DEPENDENT PREDATION
    ABRAMS, PA
    [J]. ECOLOGY, 1994, 75 (06) : 1842 - 1850
  • [2] Immunological memory and protective immunity: Understanding their relation
    Ahmed, R
    Gray, D
    [J]. SCIENCE, 1996, 272 (5258) : 54 - 60
  • [3] EFFECTS OF CYCLOSPORIN ON T-CELL SUBSETS IN HUMAN IMMUNODEFICIENCY VIRUS-DISEASE
    ANDRIEU, JM
    EVEN, P
    VENET, A
    TOURANI, JM
    STERN, M
    LOWENSTEIN, W
    AUDROIN, C
    EME, D
    MASSON, D
    SORS, H
    ISRAELBIET, D
    BELDJORD, K
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 47 (02): : 181 - 198
  • [4] SUSTAINED INCREASES IN CD4 CELL COUNTS IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SEROPOSITIVE PATIENTS TREATED WITH PREDNISOLONE FOR 1 YEAR
    ANDRIEU, JM
    LU, W
    LEVY, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) : 523 - 530
  • [5] Beddington J.R., 1975, J ANIM ECOL, V51, P597
  • [6] Human immunodeficiency virus drug therapy and virus load
    Bonhoeffer, S
    Coffin, JM
    Nowak, MA
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 3275 - 3278
  • [7] Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
    Borrow, P
    Lewicki, H
    Wei, XP
    Horwitz, MS
    Peffer, N
    Meyers, H
    Nelson, JA
    Gairin, JE
    Hahn, BH
    Oldstone, MBA
    Shaw, GM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 205 - 211
  • [8] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS
    BOUCHER, CAB
    OSULLIVAN, E
    MULDER, JW
    RAMAUTARSING, C
    KELLAM, P
    DARBY, G
    LANGE, JMA
    GOUDSMIT, J
    LARDER, BA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) : 105 - 110
  • [9] Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine
    Brichacek, B
    Swindells, S
    Janoff, EN
    Pirruccello, S
    Stevenson, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) : 1191 - 1199
  • [10] QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION
    BUKRINSKY, MI
    STANWICK, TL
    DEMPSEY, MP
    STEVENSON, M
    [J]. SCIENCE, 1991, 254 (5030) : 423 - 427